NewAmsterdam Pharma Co. NV (NAMS)

34.22 +1.23 (+3.73%) USD  |  NASDAQ  |  Apr 06, 15:02
More

NewAmsterdam Pharma EV to Revenues

EV to Revenues Chart

View EV to Revenues for NAMS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to Revenues Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to Revenues Range, Past 5 Years

View EV to Revenues Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to Revenues Benchmarks

View EV to Revenues Benchmarks
Start Trial
uniQure NV Upgrade
ProQR Therapeutics NV Upgrade
argenx SE Upgrade
Pharming Group NV Upgrade
Pharvaris NV --

EV to Revenues Related Metrics

EV to CFO Upgrade
EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade